SANARA MEDTECH INC (SMTI) Stock Analyst Earnings Estimates
NASDAQ:SMTI - Nasdaq - US79957L1008 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.84M 89.89% | 64.99M 41.78% | 86.672M 33.36% | 106.35M 22.70% | 120.77M 13.56% | |
| EBITDA YoY % growth | -9.67M -42.63% | -540.2K 94.41% | 1.029M 290.54% | N/A | N/A | |
| EBIT YoY % growth | -12.04M -63.14% | -4.215M 64.99% | -3.894M 7.62% | -7.691M -97.51% | -6.871M 10.66% | |
| Operating Margin | -26.27% | -6.49% | -4.49% | -7.23% | -5.69% | |
| EPS YoY % growth | N/A -45.98% | -0.52 59.86% | -1.14 -119.23% | -1.59 -39.58% | -1.42 10.90% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.40 -18.50% | -0.32 -75.67% | -0.31 25.73% |
| Revenue Q2Q % growth | 26.291M 21.32% | 30.524M 16.04% | 29.58M 26.23% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.964M -36.90% | -1.282M -295.90% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.23 43.90% | -0.45 | 0.22 | 48.75% |
| Q1 2025 Q2Q % growth | -0.41 -96.19% | -0.52 | 0.10 | 20.02% |
| Q4 2024 Q2Q % growth | -0.18 -500.00% | -0.12 | -0.06 | -53.45% |
| Q3 2024 Q2Q % growth | -0.34 -161.54% | -0.63 | 0.29 | 46.24% |
| Q2 2024 Q2Q % growth | -0.41 -86.36% | -0.21 | -0.20 | -91.41% |
| Q1 2024 Q2Q % growth | -0.21 -50.00% | -0.07 | -0.14 | -194.12% |
| Q4 2023 Q2Q % growth | -0.03 92.11% | -0.13 | 0.10 | 77.38% |
| Q3 2023 Q2Q % growth | -0.13 27.78% | 0.00 | -0.13 | % |
| Q2 2023 Q2Q % growth | -0.22 47.62% | -0.13 | -0.09 | -65.91% |
| Q1 2023 Q2Q % growth | -0.14 | -0.34 | 0.20 | 58.41% |
| Q4 2022 Q2Q % growth | -0.38 20.83% | -0.27 | -0.11 | -43.29% |
| Q3 2022 Q2Q % growth | -0.18 33.33% | -0.33 | 0.15 | 44.85% |
| Q2 2022 Q2Q % growth | -0.42 -162.50% | -0.29 | -0.13 | -47.06% |
| Q4 2021 Q2Q % growth | -0.48 | -0.28 | -0.20 | -74.29% |
| Q3 2021 Q2Q % growth | -0.27 | -0.18 | -0.09 | -47.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 25.83M 28.13% | 25.653M | 177K | 0.69% |
| Q1 2025 Q2Q % growth | 23.434M 26.42% | 23.945M | -511K | -2.13% |
| Q4 2024 Q2Q % growth | 26.305M 48.70% | 26.316M | -11K | -0.04% |
| Q3 2024 Q2Q % growth | 21.672M 35.24% | 21.114M | 557.6K | 2.64% |
| Q2 2024 Q2Q % growth | 20.159M 27.97% | 19.482M | 676.82K | 3.47% |
| Q1 2024 Q2Q % growth | 18.537M 19.42% | 18.87M | -333.36K | -1.77% |
| Q4 2023 Q2Q % growth | 17.69M 15.47% | 16.83M | 859.81K | 5.11% |
| Q3 2023 Q2Q % growth | 16.025M 22.89% | 19.176M | -3.151M | -16.43% |
| Q2 2023 Q2Q % growth | 15.753M 62.91% | 17.238M | -1.485M | -8.61% |
| Q1 2023 Q2Q % growth | 15.522M 98.75% | 16.524M | -1.002M | -6.06% |
| Q4 2022 Q2Q % growth | 15.32M 117.92% | 15.096M | 224K | 1.48% |
| Q3 2022 Q2Q % growth | 13.04M 124.05% | 14.994M | -1.954M | -13.03% |
| Q2 2022 Q2Q % growth | 9.67M 53.98% | 8.874M | 796K | 8.97% |
| Q1 2022 Q2Q % growth | 7.81M 55.89% | % | ||
| Q4 2021 Q2Q % growth | 7.03M 46.76% | 6.222M | 808K | 12.99% |
| Q3 2021 Q2Q % growth | 5.82M 35.03% | 6.426M | -606K | -9.43% |
| Q2 2021 Q2Q % growth | 6.28M 111.45% | % | ||
| Q1 2021 Q2Q % growth | 5.01M 42.33% | % | ||
| Q4 2020 Q2Q % growth | 4.79M 42.99% | % | ||
| Q3 2020 Q2Q % growth | 4.31M 48.11% | % | ||
| Q2 2020 Q2Q % growth | 2.97M -1.66% | % | ||
| Q1 2020 Q2Q % growth | 3.52M 41.37% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 9.28% | 0% | 12.11% |
| Revenue | 0% | -0.1% | 0% | -0.79% |